Paper40433232
Current Status of Gastric Cancer Screening and Future Perspectives.
Kusano C and 3 others. DEN Open, 2026. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Current Status of Gastric Cancer Screening and Future Perspectives. Papers, record 40433232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40433232
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11190068 | The role of economic evaluation in the diagnosis and treatment of Helicobacter pylori infection. | Gastroenterol Clin North Am | 2000 | https://conductscience.org/library/papers/11190068 | PubMed |
| 2 | 11876711 | The cost-effectiveness of population Helicobacter pylori screening and treatment: a Markov model using economic data from a randomized controlled trial. | Aliment Pharmacol Ther | 2002 | https://conductscience.org/library/papers/11876711 | PubMed |
| 3 | 26651251 | Screening of gastric cancer in Asia. | Best Pract Res Clin Gastroenterol | 2015 | https://conductscience.org/library/papers/26651251 | PubMed |
| 4 | 28147224 | Effectiveness of the Korean National Cancer Screening Program in Reducing Gastric Cancer Mortality. | Gastroenterology | 2017 | https://conductscience.org/library/papers/28147224 | PubMed |
| 5 | 24236091 | A community-based, case-control study evaluating mortality reduction from gastric cancer by endoscopic screening in Japan. | PLoS One | 2013 | https://conductscience.org/library/papers/24236091 | PubMed |
| 6 | 33538338 | Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. | CA Cancer J Clin | 2021 | https://conductscience.org/library/papers/33538338 | PubMed |
| 7 | 28279154 | Receiver operating characteristic analysis of prediction for gastric cancer development using serum pepsinogen and Helicobacter pylori antibody tests. | BMC Cancer | 2017 | https://conductscience.org/library/papers/28279154 | PubMed |
| 8 | 34278663 | Economic and health impacts of introducing Helicobacter pylori eradication strategy into national gastric cancer policy in Japan: A cost-effectiveness analysis. | Helicobacter | 2021 | https://conductscience.org/library/papers/34278663 | PubMed |
| 9 | 16331632 | Gastric cancer screening and subsequent risk of gastric cancer: a large-scale population-based cohort study, with a 13-year follow-up in Japan. | Int J Cancer | 2006 | https://conductscience.org/library/papers/16331632 | PubMed |
| 10 | 10382118 | Helicobacter pylori and gastric cancer: what are the benefits of screening only for the CagA phenotype of H. pylori? | Helicobacter | 1999 | https://conductscience.org/library/papers/10382118 | PubMed |
| 11 | 15548353 | Validity of serum pepsinogen I/II ratio for the diagnosis of gastric epithelial dysplasia and intestinal metaplasia during the follow-up of patients at risk for intestinal-type gastric adenocarcinoma. | Neoplasia | 2004 | https://conductscience.org/library/papers/15548353 | PubMed |
| 12 | 39126193 | Cost-effective endoscopic screening for gastric cancer in a cohort with low Helicobacter pylori prevalence. | J Gastroenterol Hepatol | 2024 | https://conductscience.org/library/papers/39126193 | PubMed |
| 13 | 31190581 | Cost-effectiveness of Helicobacter pylori test and eradication versus upper gastrointestinal series versus endoscopy for gastric cancer mortality and outcomes in high prevalence countries. | Scand J Gastroenterol | 2019 | https://conductscience.org/library/papers/31190581 | PubMed |
| 14 | 31648970 | The global, regional, and national burden of stomach cancer in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease study 2017. | Lancet Gastroenterol Hepatol | 2020 | https://conductscience.org/library/papers/31648970 | PubMed |
| 15 | 21741639 | Endoscopy for upper GI cancer screening in the general population: a cost-utility analysis. | Gastrointest Endosc | 2011 | https://conductscience.org/library/papers/21741639 | PubMed |
| 16 | 25314140 | Prediction of gastric cancer development by serum pepsinogen test and Helicobacter pylori seropositivity in Eastern Asians: a systematic review and meta-analysis. | PLoS One | 2014 | https://conductscience.org/library/papers/25314140 | PubMed |
| 17 | 35531944 | Gastric cancer screening: a systematic review and meta-analysis. | Scand J Gastroenterol | 2022 | https://conductscience.org/library/papers/35531944 | PubMed |
| 18 | 17912238 | X-ray screening seems to reduce gastric cancer mortality by half in a community-controlled trial in Costa Rica. | Br J Cancer | 2007 | https://conductscience.org/library/papers/17912238 | PubMed |
| 19 | 30242605 | How long should we continue gastric cancer screening? From an epidemiological point of view. | Gastric Cancer | 2019 | https://conductscience.org/library/papers/30242605 | PubMed |
| 20 | 17505999 | Reduction in gastric cancer mortality by screening based on serum pepsinogen concentration: a case-control study. | Scand J Gastroenterol | 2007 | https://conductscience.org/library/papers/17505999 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42428146 | Global stomach cancer burden from high-sodium diet and smoking: 1990-2021 findings & 2040 projections. | Front Oncol | 2026 | https://conductscience.org/library/papers/42428146 | PubMed |
| 42075532 | Prevention of Gastric Cancer. | Medicina (Kaunas) | 2026 | https://conductscience.org/library/papers/42075532 | PubMed |
| 41867005 | Cancer mortality predictions for 2026 in selected Asian countries and Australia with focus on prostate cancer. | Eur J Cancer Prev | 2026 | https://conductscience.org/library/papers/41867005 | PubMed |
| 41859297 | The Value of the Preoperative Hematological Inflammatory Markers for Predicting Lymphovascular Invasion in Gastric Cancer. | Immunotargets Ther | 2026 | https://conductscience.org/library/papers/41859297 | PubMed |
| 41824387 | The role of phase angle and standardized phase angle in assessing nutritional status and predicting complications in gastrointestinal cancer. | PLoS One | 2026 | https://conductscience.org/library/papers/41824387 | PubMed |
| 41347071 | Enhancing cancer risk awareness and screening management through artificial intelligence: a narrative review. | Front Oncol | 2025 | https://conductscience.org/library/papers/41347071 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40433232
GET https://conductscience.org/api/papers/v1/40433232/references?page=2